Results 91 to 100 of about 1,533 (199)
The theragnostic advances of exosomes in managing leukaemia
Journal of Cellular and Molecular MedicineAbstractLeukaemia, a group of haematological malignancies, presents ongoing diagnosis, prognosis, and treatment challenges. A major obstacle in treating this disease is the development of drug resistance. Overcoming drug resistance poses a significant barrier to effective leukaemia treatment.
Subhrojyoti Ghosh +11 more
openaire +2 more sources
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
The prevalence of Alzheimer's disease (AD) and its associated economic and societal burdens are on the rise, but there are no curative treatments for AD.
Hong, Jin Tae +7 more
core +1 more source
Bionanosensors in early-stage theragnostics
Bionanosensors in early-stage theragnostics Abstract The thesis focuses on the development and application of nanomaterials in the field of theranostics, combining diagnostics and targeted drug delivery within the framework of personalized medicine.
Pashchenko, Aleksei
core +1 more source
Theragnostics, Intellectual Property & Ethics [PDF]
, 2012 Relatório apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do título de agregado em Biotecnologia e Saúde, especialização em Química ...
Souto, Eliana Maria Barbosa
core
Targeted Lipid Nanocarriers for Theragnostics [PDF]
, 2012 Lição (sumário) apresentada à Universidade Fernando Pessoa como parte dos requisitos para obtenção do título de agregado em Biotecnologia e Saúde, especialização em Química ...
Souto, Eliana Maria Barbosa
core
, 2012 Omics, 16, 79-89Note : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY.
Yoon, D.S. +6 more
core +1 more source
Prostate-specific membrane antigen-mediated theragnostics in prostate cancer [PDF]
Investigative and Clinical Urology, 2021 Seung-hwan Jeong, Cheol Kwak
doaj +1 more source
Next-level precision medicine: why the theragnostic approach is the future
Theragnostics represents one of the most innovative fields of precision medicine with a huge potential in the field of oncology in the next years.
DI GREZIA, Graziella +4 more
core +1 more source
Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics
, 2011 In the emerging field of molecular and cellular imaging, flexible strategies to synthesize multimodal contrast agents with targeting ligands are required.
Luce Vander Elst +5 more
core +1 more source
Clinical platforms in NET patients treated with radioligand therapy: a dosimetric comparison
, 2023 Background: this work aims to compare absorbed doses between different platforms developed for Radioligand Therapy (RLT). Data analysis concerned dosimetric monitoring of kidneys and significant lesions (ROIs) in NET patients treated with Lu-177-DOTATOC.
A. Turra +10 more
core